We are live on ! Find out more
ELDN icon

Eledon Pharmaceuticals
ELDN

53 hedge funds and large institutions have $46M invested in Eledon Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 9

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

8% more funds holding

Funds holding: 49 → 53 (+4)

34% less capital invested

Capital invested by funds: $69.4M → $46M (-$23.5M)

Holders
53
Holders Change
+4
Holders Change %
+8.16%
% of All Funds
1.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
20
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$2.93M
2
Ameriprise
Ameriprise
Minnesota
+$1.89M
3
OPPM
Opus Point Partners Management
New York
+$667K
4
Renaissance Technologies
Renaissance Technologies
New York
+$453K
5
PI
Putnam Investments
Massachusetts
+$352K

Top Sellers

Rank Fund Capital Flow
1
NHAS
Novo Holdings A/S
Denmark
-$8.25M
2
SM
Sabby Management
Florida
-$6.77M
3
KCM
Kingdon Capital Management
New York
-$6.13M
4
JP Morgan Chase
JP Morgan Chase
New York
-$1.02M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$922K
Name Holding Trade Value Shares
Change 		Change in
Stake
ARTA
26
A.R.T. Advisors
New York
$239K +$296K +170 New
CS
27
Credit Suisse
Switzerland
$175K +$216K +124 New
ProShare Advisors
28
ProShare Advisors
Maryland
$170K +$211K +121 New
D.E. Shaw & Co
29
D.E. Shaw & Co
New York
$158K +$195K +112 New
Charles Schwab
30
Charles Schwab
California
$157K – – –
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$153K +$5.23K +3 +3%
Goldman Sachs
32
Goldman Sachs
New York
$146K +$47K +27 +36%
Bank of America
33
Bank of America
North Carolina
$129K +$138K +79 +608%
TA
34
Teachers Advisors
New York
$121K – – –
Citigroup
35
Citigroup
New York
$111K +$62.7K +36 +86%
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$94K +$8.71K +5 +8%
BCM
37
Bridgeway Capital Management
Texas
$87K – – –
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$75K – – –
NFA
39
Nationwide Fund Advisors
Ohio
$53K – – –
RWA
40
Ropes Wealth Advisors
Massachusetts
$52K – – –
AIG
41
American International Group
New York
$48K – – –
Morgan Stanley
42
Morgan Stanley
New York
$45K +$6.97K +4 +15%
BA
43
BlackRock Advisors
Delaware
$36K -$20.9K -12 -32%
Creative Planning
44
Creative Planning
Kansas
$29K – – –
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$22.3K +$5.23K +3 +23%
CG
46
Colony Group
Massachusetts
$17K – – –
UBS Group
47
UBS Group
Switzerland
$11K +$3.48K +2 +33%
TRCT
48
Tower Research Capital (TRC)
New York
$10K +$12.2K +7 New
BJ
49
BlackRock Japan
Japan
$9K +$10.5K +6 New
Barclays
50
Barclays
United Kingdom
$4K +$5.23K +3 New
1
2
3

ELDN Hedge Fund Activity: Q4 2015 in Review

53 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Eledon Pharmaceuticals (ELDN) for Q4 2015, worth a combined $46M — down 34% from $69.4M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ELDN positions and 6 closed out — a net gain of 4 holders — while 20 added to existing stakes and 9 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $2.93M. The largest seller was Novo Holdings A/S, cutting an estimated $8.25M.

  • 53 institutional investors held Eledon Pharmaceuticals (ELDN) as of Q4 2015, up from 49 in Q3 2015.
  • Funds reported $46M of Eledon Pharmaceuticals stock for Q4 2015, down 34% quarter-over-quarter.
  • 10 funds opened new Eledon Pharmaceuticals positions in Q4 2015 and 6 closed out, a net change of +4 holders.
  • The largest Eledon Pharmaceuticals buyer in Q4 2015 was BlackRock Fund Advisors, an estimated $2.93M added.
  • The largest Eledon Pharmaceuticals seller in Q4 2015 was Novo Holdings A/S, an estimated $8.25M sold.

Based on aggregated 13F filings for Q4 2015.